Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Phibro Animal Health (PAHC) Amortization of Deferred Charges (2016 - 2025)

Historic Amortization of Deferred Charges for Phibro Animal Health (PAHC) over the last 13 years, with Q4 2025 value amounting to $572000.0.

  • Phibro Animal Health's Amortization of Deferred Charges rose 1349.21% to $572000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.3 million, marking a year-over-year increase of 6448.6%. This contributed to the annual value of $2.0 million for FY2025, which is 9375.0% up from last year.
  • Per Phibro Animal Health's latest filing, its Amortization of Deferred Charges stood at $572000.0 for Q4 2025, which was up 1349.21% from $572000.0 recorded in Q3 2025.
  • Phibro Animal Health's Amortization of Deferred Charges' 5-year high stood at $572000.0 during Q1 2025, with a 5-year trough of $147000.0 in Q4 2021.
  • For the 5-year period, Phibro Animal Health's Amortization of Deferred Charges averaged around $295400.0, with its median value being $240500.0 (2021).
  • Its Amortization of Deferred Charges has fluctuated over the past 5 years, first tumbled by 3348.42% in 2022, then soared by 12000.0% in 2025.
  • Phibro Animal Health's Amortization of Deferred Charges (Quarter) stood at $147000.0 in 2021, then rose by 21.77% to $179000.0 in 2022, then soared by 45.25% to $260000.0 in 2023, then soared by 93.85% to $504000.0 in 2024, then grew by 13.49% to $572000.0 in 2025.
  • Its last three reported values are $572000.0 in Q4 2025, $572000.0 for Q3 2025, and $572000.0 during Q2 2025.